Fachliteratur Gastroenterologie: Neoplasien Oesophagus

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Oesophagus » Neoplasie

29. Juli 2026

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 1969


	Artikel 1 - 20 / 39379

	Cancer outcomes and biological mechanisms among patients with type 2 diabetes mellitus using glucagon-like peptide-1 receptor agonists: a systematic review and meta-analysis. Front Oncol Eze ED, Ntakirutimana L, Terkimbi SD, Walle M, Umar AH, Wondimu DH, Olubiyi MV, Okeke OC, Onaadepo O, Abdulazeez J, Ikwuka DC, Ani EJ, Alagbonsi AI. PMID: 42523690 [PubMed - as supplied by publisher]
	Prediction of anastomotic leakage after esophagectomy for esophageal cancer: a nomogram study integrating systemic inflammation indices and clinical factors. Front Oncol Tan R, Guo L, Li S, Huang W, Zhang H, Gu T, Ba Q. PMID: 42523643 [PubMed - as supplied by publisher]
	Diagnostic performance of whole-body diffusion-weighted imaging for staging esophageal cancer: a comparative study with PET-CT. Radiol Oncol Xu X, Yu R, Ma Q, Yin T, Chen H, Qian Y, Li H, Qi R, Xu Y. PMID: 42522422 [PubMed - as supplied by publisher]
	Prognostic analysis of patients with esophageal squamous cell carcinoma based on tumor differentiation in the setting of neoadjuvant chemotherapy combined with immunotherapy: A single-center retrospective study. Eur J Surg Oncol Ding W, Liu L, Sheng Q, Li S, Liu Y, Wu B, Lv H. PMID: 42520554 [PubMed - as supplied by publisher]
	Barriers to Guideline-Based Management of Esophageal Carcinoma: A Narrative Review With Special Reference to North East India. Cureus Kumar S, Ghosh S, Chyrmang D, Dey B, Ghosh T, Singh B. PMID: 42519253 [PubMed - as supplied by publisher]
	Integrative Mendelian Randomization and Single-Cell Pseudotime Analysis Reveal DKK3 as a PI3K-AKT-Modulated Driver of Esophageal Squamous Cell Carcinoma. Hum Mutat Huang Z, Cao T, Zhou YL, Shi J. PMID: 42518368 [PubMed - as supplied by publisher]
	Neoadjuvant chemotherapy and surgery-based treatment with selective adjuvant chemotherapy for cT2N0 esophageal squamous cell carcinoma: a multicenter retrospective study. Esophagus Takeoka T, Miyata H, Tanaka K, Nakai S, Sugase T, Yamamoto M, Kanemura T, Sugimura K, Makino T, Takeno A, Shiraishi O, Motoori M, Yamasaki M, Hirao M, Fujitani K, Yasuda T, Yano M, Doki Y. PMID: 42518071 [PubMed - as supplied by publisher]
	MARVELD3 as a Prognostic Biomarker in Esophageal Cancer and its Relationship with m6A Modification, Cuproptosis, and the ceRNA Regulatory Network. Curr Gene Ther Fan W, Huang C, Wang Z, Sun S, Li K, Liu X, Wang Z, Zhao T, Zhang G, Pan X. PMID: 42517389 [PubMed - as supplied by publisher]
	Return-To-Work and Working Status After Surgery for Gastric and Esophageal Cancer: A Prospective Observational Study. Ann Gastroenterol Surg Goto K, Hisamori S, Ueno K, Abe H, Okamura R, Hosogi H, Yamashita Y, Manaka D, Hata H, Nishigori T, Nakajima S, Yamamoto M, Kinoshita K, Okumura S, Sakaguchi M, Tsunoda S, Sakagami Y, Hida K, Obama K. PMID: 42516536 [PubMed - as supplied by publisher]
	Neoadjuvant chemoimmunotherapy versus chemoradiotherapy for esophageal squamous cell carcinoma: a multicenter cohort study. Front Immunol Zhu Y, Hou Z, Sun Y, Xu L, Cao Y, Liang L, Yu Y, Lan M, Fan M, Peng L, Leng X, Wang C, Gao L, Zheng J, Wu L, Xiao Z, Huang W, Wu M, Zhang W, Li H, Wang Q. PMID: 42516383 [PubMed - as supplied by publisher]
	Correlation between semiquantitative and quantitative [18F]FDG PET/CT parameters and serum tumor marker levels in recurrent esophageal carcinoma: up to 12-year follow-up study. Nucl Med Rev Cent East Eur Kotur M, Pantic N, Odalovic S, Grujicic L, Grozdic Milojevic I, Petrovic J, Stojiljkovic M, Sobic Saranovic D, Artiko V. PMID: 42516111 [PubMed - as supplied by publisher]
	The Association Between Gastroesophageal Reflux Disease and Lung Cancer: A Systematic Review and Meta Analysis. J Clin Med Abureesh O, Sange W, Al Zureikat Q, Habib T, Abu-Shaban M, Rababah G, Yousef Y, Abdulraheem A, Plann-Curley B, Deeb L. PMID: 42513339 [PubMed - in process]
	Cancer-Associated Fibroblast Heterogeneity and Extracellular Matrix Remodeling as Orchestrators of Drug Resistance in Upper Gastrointestinal Cancers: Insights from Spatial Multi-Omics and Therapeutic Implications. Cancers (Basel) Mirzabeigi Y, Youssef J, Gonzalez J, Martinez T, Avellan R, Wong A, Perez M, Carvajal LL, Abou-Kheir W, Bahmad HF. PMID: 42512419 [PubMed - in process]
	Applications of Artificial Intelligence in the Endoscopic Detection and Characterization of Early Esophageal Squamous Cell Carcinoma: A Scoping Review. Cancers (Basel) Rodríguez-Velásquez F, Montoya-Durán A, Bonilla N, Echeverri-Hoyos J, Echeverri-Franco JA, Tuta-Quintero E. PMID: 42512301 [PubMed - in process]
	Ancillary Studies in the Diagnosis and Classification of Barrett Esophagus: What's on the Menu? Surg Pathol Clin Hutchings DA, Montgomery EA. PMID: 42508928 [PubMed - indexed for MEDLINE]
	Circulating Tumour DNA and Molecular Residual Disease in Oesophageal Cancer: Clinical Readiness, Evidence Gaps and Trial-Ready Applications. Crit Rev Oncol Hematol Meng YQ, Li HT, Zhang G, Lin JP, Hui YM. PMID: 42508592 [PubMed - as supplied by publisher]
	DNA methylation profiling enables subclassification of mucinous ovarian carcinoma and distinguishes it from extraovarian mucinous metastases. Cell Rep Med Calina TG, Grafenhorst E, Schallenberg S, Möbs M, Daenekas B, Sabo AA, Chen B, Koch I, Janik T, Churchman M, Gourley C, Christie EL, Vasilescu C, Herlea V, Schmitt WD, Leopold N, Heitz F, Vlaski A, Tolkach Y, Bremmer F, Klauschen F, Büttner R, Ströbel P, Burandt E, Sauter G, Heppner FL, Taube ET, Sehouli J, Braicu IE, Euskirchen P, Horst D, Gorringe KL, Capper D, Dragomir MP. PMID: 42508406 [PubMed - as supplied by publisher]
	Surveillance vs Standard Surgery and Cost-Effectiveness After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open Gangaram Panday SSG, van Klaveren D, Lagarde SM, van der Wilk BJ, Eyck BM, Rosman C, Noordman BJ, Valkema MJ, Bisseling TM, Coene PLO, Dekker JWT, van Det MJ, van Dieren JM, Doukas M, van Esser S, Fiets WE, Hartgrink HH, Heisterkamp J, Hol L, Klarenbeek B, Kouw E, Kouwenhoven EA, Luyer MD, Mostert B, Nieuwenhuijzen GAP, Oostenbrug LE, Oude Voshaar M, Pierie JP, van Sandick JW, Sosef MN, Spaander MCW, Steyerberg EW, Valkema R, van der Zaag ES, van Lanschot JJB, Lingsma HF, Wijnhoven BPL, Surgery as Needed for Oesophageal Cancer (SANO) Study Group. PMID: 42507446 [PubMed - indexed for MEDLINE]
	Comparison of induction chemotherapy followed by concurrent chemoradiotherapy versus neoadjuvant chemotherapy followed by surgery and (chemo)radiotherapy in locoregionally advanced hypopharyngeal carcinoma: a prospective cohort study. Clin Transl Oncol Zhao DW, Li SR, Yang F, Guo XF, Sun XZ, Li L, Tan SC, Qin JY, Qu YJ, Wang ZQ, Ma L, Wang PG. PMID: 42507334 [PubMed - as supplied by publisher]
	Adaptive 3D-CRT with CCRT for head and neck cancer: resource limited single center experience in Bangladesh. Radiol Phys Technol Al-Amin, Das PK, Saha SK, Mannan A, Tania AB, Alim S, Poddar P, Hasnat A, Islam R. PMID: 42507086 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 39379

Seite 1 von 1969



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung